James Karrels
2013
In 2013, James Karrels earned a total compensation of $1.2M as Senior Vice President, Chief Financial Officer and Corporate Secretary at MacroGenics.
Compensation breakdown
| Non-Equity Incentive Plan | $123,296 |
|---|---|
| Option Awards | $800,763 |
| Salary | $306,748 |
| Other | $3,825 |
| Total | $1,234,632 |
Karrels received $800.8K in option awards, accounting for 65% of the total pay in 2013.
Karrels also received $123.3K in non-equity incentive plan, $306.7K in salary and $3.8K in other compensation.
Rankings
In 2013, James Karrels' compensation ranked 5,723rd out of 12,286 executives tracked by ExecPay. In other words, Karrels earned more than 53.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,723 out of 12,286 | 53rd |
Division Manufacturing | 1,992 out of 4,612 | 57th |
Major group Chemicals And Allied Products | 581 out of 1,466 | 60th |
Industry group Drugs | 416 out of 1,160 | 64th |
Industry Pharmaceutical Preparations | 335 out of 890 | 62nd |
Source: SEC filing on April 7, 2016.
Karrels' colleagues
We found three more compensation records of executives who worked with James Karrels at MacroGenics in 2013.
News
MacroGenics CEO Scott Koenig's 2023 pay slips 20% to $3.7M
April 8, 2024
MacroGenics CEO Scott Koenig's 2022 pay slips 5% to $4.6M
April 17, 2023
MacroGenics CEO Scott Koenig's 2021 pay jumps 56% to $4.9M
April 8, 2022
MacroGenics Chief Medical Officer Stephen Eck receives $5.1M in 2020
April 1, 2021
MacroGenics CEO Scott Koenig's 2019 pay slips 9% to $4.7M
April 2, 2020